Western European In Vitro Diagnostics (IVD) Market

The aim of this research service is to thoroughly assess and analyse the in vitro diagnostics market in Western European countries and provide strategic recommendations and conclusions for the success of market participants. This study provides an understanding of the key segments (immunochemistry, microbiology, molecular diagnostics, POCT, SMBG, tissue diagnostics, haematology and haemostasis), likely future trends, revenue forecasts and competitive analyses. It also provides an analysis of the IVD markets in the United Kingdom, Germany, France, Italy, Spain, Benelux (Belgium, the Netherlands and Luxembourg) and Scandinavia (Denmark, Norway, Sweden and Finland).

Executive Summary

•The Western European IVD market is expected to continue growing from $xx,xxx.x million in 2011 to $xx,xxx.x million in 2018 at a compound annual growth rate (CAGR) of x.x per cent.
•Existing competitors have realised the market potential, and they take steps to constantly improve their products and services in emerging segments such as molecular diagnostics and point-of-care testing (POCT).
•Large international companies such as Roche, Siemens and Abbott dominate the market. This trend is predicted to continue.
•The market may witness an increase in competition, partnerships, licence agreements and mergers.
•Increasing trend of industry consolidation may witness large international companies with marketing expertise acquiring smaller companies and new entrants with R&D and technology expertise.
•The IVD market is technology driven. Increasing demand for IVD testing will require improved products and long-term post-sales service.
•Market participants may need to develop solutions best suited for customer needs to remain competitive.
•Due to the high competition and rising costs of diagnostic products and services, improved sales and market strategies are required, along with long-term partnerships with companies.

In Vitro Diagnostic Industry in Europe

TABLE OF CONTENTS

Executive Summary 5
Market Overview 10
Total IVD Market -
Industry Challenges 17
External Challenges: Drivers and Restraints 21
Forecasts and Trends 26
Market Share and Competitive Analysis 31
Segment Analysis 48
Immunochemistry Segment Breakdown 50
Microbiology Segment Breakdown 58
Molecular Diagnostics Segment Breakdown 66
Point-of-Care Testing (POCT) Segment Breakdown 74
Self-monitoring of Blood Glucose (SMBG) Segment Breakdown 82
Tissue Diagnostics Segment Breakdown 90
Haematology Segment Breakdown 98
Haemostasis Segment Breakdown 106
Regional Analysis 114
IVD Market in The United Kingdom 117
IVD Market in Germany 124
IVD Market in France 131
IVD Market in Italy 138
IVD Market in Spain 144
IVD Market in Benelux 150
IVD Market in Scandinavia 156
Conclusions and Strategic Recommendations 162
The Last Word (Conclusions and Implications) 165
Appendix 168